logo
Menu
Innovation Observatory > Reports > Drugs > Ponesimod for Relapsing-remitting Multiple Sclerosis

< Back

Ponesimod for Relapsing-remitting Multiple Sclerosis

Drugs

Neurology and Neurosurgery

November 2017


Ponesimod is a drug which works by blocking the signals which allow the body’s immune cells to travel to and damage the nerve cells. By preventing the immune cells from damaging the nerves, it is thought this drug will stop the damage which causes MS ‘relapses’. In clinical trials it has been shown that ponesimod reduces the number of ‘relapses’ in people with MS and reduced the amount of damage to the nerves (measured by brain scans) compared to a placebo.

Innovation Observatory Voice 0

Leave a Reply

Your email address will not be published. Required fields are marked *

Post Comment

Ponesimod for Multiple Sclerosis



 

Connect to the Innovation Observatory

Twitter

Load More Related Posts
Get Alerts